Nordea Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $819K | Buy |
14,944
+66
| +0.4% | +$3.62K | ﹤0.01% | 836 |
|
2025
Q1 | $1.05M | Buy |
14,878
+56
| +0.4% | +$3.94K | ﹤0.01% | 800 |
|
2024
Q4 | $977K | Hold |
14,822
| – | – | ﹤0.01% | 812 |
|
2024
Q3 | $1.04M | Sell |
14,822
-30
| -0.2% | -$2.11K | ﹤0.01% | 800 |
|
2024
Q2 | $1.24M | Buy |
14,852
+1,177
| +9% | +$98.2K | ﹤0.01% | 779 |
|
2024
Q1 | $1.21M | Buy |
13,675
+2,081
| +18% | +$184K | ﹤0.01% | 793 |
|
2023
Q4 | $1.12M | Buy |
11,594
+544
| +5% | +$52.6K | ﹤0.01% | 805 |
|
2023
Q3 | $983K | Sell |
11,050
-521
| -5% | -$46.4K | ﹤0.01% | 810 |
|
2023
Q2 | $1.05M | Hold |
11,571
| – | – | ﹤0.01% | 800 |
|
2023
Q1 | $1.12M | Hold |
11,571
| – | – | ﹤0.01% | 767 |
|
2022
Q4 | $1.18M | Hold |
11,571
| – | – | ﹤0.01% | 743 |
|
2022
Q3 | $996K | Buy |
11,571
+581
| +5% | +$50K | ﹤0.01% | 778 |
|
2022
Q2 | $906K | Buy |
10,990
+2,362
| +27% | +$195K | ﹤0.01% | 808 |
|
2022
Q1 | $668K | Hold |
8,628
| – | – | ﹤0.01% | 860 |
|
2021
Q4 | $772K | Hold |
8,628
| – | – | ﹤0.01% | 853 |
|
2021
Q3 | $666K | Hold |
8,628
| – | – | ﹤0.01% | 884 |
|
2021
Q2 | $720K | Hold |
8,628
| – | – | ﹤0.01% | 863 |
|
2021
Q1 | $656K | Hold |
8,628
| – | – | ﹤0.01% | 855 |
|
2020
Q4 | $757K | Buy |
8,628
+948
| +12% | +$83.2K | ﹤0.01% | 798 |
|
2020
Q3 | $590K | Sell |
7,680
-7,680
| -50% | -$590K | ﹤0.01% | 793 |
|
2020
Q2 | $1.89M | Buy |
15,360
+7,680
| +100% | +$944K | ﹤0.01% | 722 |
|
2020
Q1 | $634K | Buy |
7,680
+383
| +5% | +$31.6K | ﹤0.01% | 763 |
|
2019
Q4 | $615K | Hold |
7,297
| – | – | ﹤0.01% | 809 |
|
2019
Q3 | $497K | Buy |
7,297
+657
| +10% | +$44.7K | ﹤0.01% | 846 |
|
2019
Q2 | $569K | Sell |
6,640
-525
| -7% | -$45K | ﹤0.01% | 836 |
|
2019
Q1 | $637K | Sell |
7,165
-41
| -0.6% | -$3.65K | ﹤0.01% | 1049 |
|
2018
Q4 | $613K | Hold |
7,206
| – | – | ﹤0.01% | 1031 |
|
2018
Q3 | $699K | Buy |
7,206
+147
| +2% | +$14.3K | ﹤0.01% | 1063 |
|
2018
Q2 | $665K | Sell |
7,059
-57,190
| -89% | -$5.39M | ﹤0.01% | 900 |
|
2018
Q1 | $5.21M | Sell |
64,249
-12,660
| -16% | -$1.03M | 0.01% | 437 |
|
2017
Q4 | $6.86M | Sell |
76,909
-21,130
| -22% | -$1.88M | 0.02% | 372 |
|
2017
Q3 | $9.12M | Sell |
98,039
-4,426
| -4% | -$412K | 0.02% | 303 |
|
2017
Q2 | $9.31M | Sell |
102,465
-8,700
| -8% | -$790K | 0.02% | 284 |
|
2017
Q1 | $9.76M | Buy |
111,165
+5,164
| +5% | +$453K | 0.03% | 277 |
|
2016
Q4 | $8.78M | Buy |
106,001
+8,558
| +9% | +$709K | 0.02% | 281 |
|
2016
Q3 | $9.02M | Sell |
97,443
-2,274
| -2% | -$210K | 0.02% | 273 |
|
2016
Q2 | $7.76M | Buy |
99,717
+25,600
| +35% | +$1.99M | 0.02% | 258 |
|
2016
Q1 | $6.11M | Buy |
74,117
+70,640
| +2,032% | +$5.83M | 0.02% | 271 |
|
2015
Q4 | $364K | Hold |
3,477
| – | – | ﹤0.01% | 668 |
|
2015
Q3 | $366K | Buy |
3,477
+300
| +9% | +$31.6K | ﹤0.01% | 608 |
|
2015
Q2 | $435K | Hold |
3,177
| – | – | ﹤0.01% | 596 |
|
2015
Q1 | $396K | Hold |
3,177
| – | – | ﹤0.01% | 621 |
|
2014
Q4 | $287K | Buy |
3,177
+1,545
| +95% | +$140K | ﹤0.01% | 665 |
|
2014
Q3 | $118K | Sell |
1,632
-2,031
| -55% | -$147K | ﹤0.01% | 755 |
|
2014
Q2 | $228K | Sell |
3,663
-20,000
| -85% | -$1.24M | ﹤0.01% | 747 |
|
2014
Q1 | $1.61M | Sell |
23,663
-2,634
| -10% | -$180K | 0.01% | 467 |
|
2013
Q4 | $1.85M | Hold |
26,297
| – | – | 0.01% | 450 |
|
2013
Q3 | $1.9M | Sell |
26,297
-60,000
| -70% | -$4.33M | 0.01% | 447 |
|
2013
Q2 | $4.82M | Buy |
+86,297
| New | +$4.82M | 0.03% | 285 |
|